Meeder Advisory Services Inc. Buys Shares of 61,369 Kenvue Inc. $KVUE

Meeder Advisory Services Inc. purchased a new position in Kenvue Inc. (NYSE:KVUE) in the second quarter, Holdings Channel reports. The fund purchased 61,369 shares of the company’s stock, valued at approximately $1,173,000.

Other large investors also recently made changes to their positions in the company. CoreCap Advisors LLC increased its holdings in shares of Kenvue by 64.9% during the 2nd quarter. CoreCap Advisors LLC now owns 1,502 shares of the company’s stock valued at $29,000 after acquiring an additional 591 shares during the last quarter. Montag A & Associates Inc. lifted its holdings in Kenvue by 6.3% in the 1st quarter. Montag A & Associates Inc. now owns 10,156 shares of the company’s stock worth $175,000 after purchasing an additional 600 shares during the last quarter. Cornerstone Wealth Group LLC boosted its position in Kenvue by 5.9% during the first quarter. Cornerstone Wealth Group LLC now owns 10,810 shares of the company’s stock worth $187,000 after purchasing an additional 606 shares during the period. Physician Wealth Advisors Inc. boosted its position in Kenvue by 67.5% during the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after purchasing an additional 618 shares during the period. Finally, Mill Creek Capital Advisors LLC grew its holdings in Kenvue by 0.6% during the fourth quarter. Mill Creek Capital Advisors LLC now owns 124,213 shares of the company’s stock valued at $2,143,000 after purchasing an additional 701 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Kenvue Trading Up 1.9%

Shares of KVUE stock opened at $19.16 on Thursday. The firm has a fifty day moving average of $19.02 and a 200-day moving average of $18.18. The stock has a market cap of $36.80 billion, a price-to-earnings ratio of 22.02, a P/E/G ratio of 1.35 and a beta of 0.47. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $21.84. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.71 and a current ratio of 1.01.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, August 6th. The company reported $0.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The company had revenue of $3.96 billion during the quarter, compared to analyst estimates of $3.97 billion. During the same period in the previous year, the company posted $0.29 earnings per share. The company’s quarterly revenue was up 3.0% on a year-over-year basis. On average, equities research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, August 26th. Investors of record on Wednesday, August 12th will be issued a $0.21 dividend. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.4%. The ex-dividend date of this dividend is Wednesday, August 12th. Kenvue’s dividend payout ratio (DPR) is presently 96.55%.

Analysts Set New Price Targets

KVUE has been the topic of a number of research analyst reports. UBS Group lowered their target price on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a research note on Tuesday, August 11th. Barclays upped their price target on shares of Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a report on Tuesday, July 21st. Zacks Research downgraded Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 7th. Wall Street Zen lowered Kenvue from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Finally, Weiss Ratings raised Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 15th. Three research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $19.27.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.